Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

Share Price is delayed by 15 minutes
Get Live Data
45.85    0.05 (0.11%)
Bid:
45.60
Ask:
45.90
Spread: 0.30 (0.658%)
Market Cap: £290.17m
MARS Live PriceLast checked at - London Stock Exchange

Intraday Marstons Share Chart

Successful Securitisation

19 Nov 2007 13:18

Marston's PLC19 November 2007 19 November 2007 Marston's PLC Successful Securitisation Issue Marston's PLC ("Marston's", and together with its subsidiaries the "Marston'sGroup" or "the Group") has finalised the terms of a £330m tap issue of Marston'sIssuer PLC (formerly W&DB Issuer PLC) securitisation. This is backed by thetransfer of 437 freehold and long-leasehold tenanted pubs from thenon-securitised estate to the securitised estate. The pro-forma run-rate EBITDAfor the enlarged securitisation group as at 30 June 2007 was £147.3m.Additionally, Marston's will retain £400m of its existing bank facilities.Following the tap issue only approximately £150m will be drawn against thesefacilities, providing the Group with significant financial and operationalflexibility. The terms of the tap issue are announced today and the transaction is expectedto be completed this week. The refinancing delivers significant benefits toMarston's: • highly competitive ongoing cost of funds with a weighted average margin for the tap issue of 0.80% over Libor, resulting in interest cost of the new issuance of 6.03%, including the costs of hedging.• improves the efficiency of the Group's debt funding, replacing short-term bank borrowing with long term securitised financing.• enhanced operational and financial flexibility within the revised debt structure.• all of the Group's debt is now at effective fixed rates of interest, with no refinancing risk or exposure to volatile credit markets. Marston's tap issue is the only pub securitisation, and one of the very fewsecuritisations in Europe, to have been launched successfully and priced inrecent months. Paul Inglett, Group Finance Director, said "Despite adverse market conditions,the terms of the refinancing demonstrate the strength of Marston's creditprofile and the high quality of its pub estate". The securitisation tap issue has been pre-placed. The pricing of the tap issueis in line with previous pub securitisations and is very competitive given thecurrent difficult conditions in the securitisation markets. The securitisationtap issue priced at the following levels: Tranche Rating (S&P/F) Type Maturity Amount Coupon A4 A/A FRN 2031 £250m Libor + 65 bps1AB1 BBB+/BBB+ FRN 2035 £80m Libor + 125 bps1Total £330m Libor + 80 bps2 Note 1: The FRNs are fully hedged and will be issued at a discount to par priceof 99.95%Note 2: This is the weighted average margin to a step-up in coupon at year 5 As a result of the interest rate swaps put in place in October and the £330m tapof the securitisation, all of the Group's borrowings are now effectively atfixed rates of interest with a blended average cost of debt of approximately6.1%. Marston's will be holding a bondholder presentation on Monday 3rd December at9.30am at the offices of Hudson Sandler, 29 Cloth Fair, London, EC1A 7NN. Pleasecontact Vanessa Laybourn at Hudson Sandler on 020 7796 4133 for details. The Royal Bank of Scotland plc acted as the Arranger, Joint Bookrunner and JointLead Manager in the transaction. HSBC Bank plc is a Joint Bookrunner and JointLead Manager and Barclays Capital is a Joint Lead Manager on the transaction. NMRothschild & Sons Limited advised Marston's on its refinancing strategy. Contact details Marston's PLC Ralph Findlay, Chief Executive 01902 329 516Paul Inglett, Group Finance Director 01902 329 516 The Royal Bank of Scotland plc (Arranger and Joint Bookrunner) Colin Lally, Director 020 7085 6668Paul Crawford, Director 020 7085 5165 NM Rothschild & Sons Limited (Financial Adviser to Marston's) Tom Smyth, Managing Director 020 7280 5719Swagata Ganguly, Assistant Director 020 7280 5676 Hudson Sandler (PR Adviser to Marston's) Andrew Hayes 020 7796 4133Nick Lyon 020 7796 4133 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
1st Jun 20262:38 pmRNSTotal Voting Rights
19th May 202611:12 amRNSDirector Declaration
12th May 20267:00 amRNSRESULTS FOR THE 26 WEEKS ENDED 28 MARCH 2026
1st Apr 20263:12 pmRNSTotal Voting Rights
2nd Mar 202611:43 amRNSTotal Voting Rights
23rd Feb 20265:33 pmRNSHolding(s) in Company
11th Feb 202611:21 amRNSDirector/PDMR Shareholding
2nd Feb 20263:28 pmRNSTotal Voting Rights
28th Jan 202612:37 pmRNSResult of AGM
28th Jan 20267:00 amRNSTrading update for the 17 weeks to 24 January 2026
12th Jan 20262:00 pmRNSBlock listing Interim Review
9th Jan 20269:30 amRNSPurchase of shares into the EBT
2nd Jan 20262:55 pmRNSTotal Voting Rights
29th Dec 202510:46 amRNSDirector/PDMR Shareholding
29th Dec 202510:46 amRNSDirector/PDMR Shareholding
29th Dec 202510:44 amRNSDirector/PDMR Shareholding
29th Dec 202510:44 amRNSDirector/PDMR Shareholding
12th Dec 202511:07 amRNSAnnual Financial Report
11th Dec 20259:54 amRNSPurchase of shares into the EBT
1st Dec 20254:15 pmRNSTotal Voting Rights
28th Nov 202512:36 pmRNSDirector/PDMR Shareholding
28th Nov 202512:30 pmRNSDirector/PDMR Shareholding
25th Nov 20257:00 amRNSPRELIMINARY RESULTS
28th Oct 20254:54 pmRNSHolding(s) in Company
8th Oct 20257:00 amRNSTrading Update for 52 weeks to 27 September 2025
1st Oct 20254:16 pmRNSTotal Voting Rights
1st Sep 20253:22 pmRNSTotal Voting Rights
1st Aug 20254:17 pmRNSTotal Voting Rights
22nd Jul 20257:00 amRNSTrading Update for the 41 weeks to 12 July 2025
9th Jul 20252:35 pmRNSBlock listing Interim Review
1st Jul 20255:03 pmRNSTotal Voting Rights
26th Jun 20257:05 amRNSAppointment of Chief Financial Officer
13th May 20257:00 amRNSRESULTS FOR THE 26 WEEKS ENDED 29 MARCH 2025
1st May 20253:04 pmRNSTotal Voting Rights
1st Apr 20251:40 pmRNSTotal Voting Rights
20th Mar 202512:48 pmRNSPurchase of shares into the EBT
17th Mar 20251:10 pmRNSPurchase of shares into the EBT
4th Mar 20257:00 amRNSDirectorate Change
25th Feb 20259:24 amRNSHolding(s) in Company
21st Jan 20253:21 pmRNSResult of AGM
21st Jan 20257:00 amRNSTrading Update for the 16 weeks to 18 January 2025
13th Jan 20253:36 pmRNSPurchase of shares into the EBT
10th Jan 202510:13 amRNSBlock listing Interim Review
8th Jan 202511:55 amRNSHolding(s) in Company
2nd Jan 202511:27 amRNSTotal Voting Rights
23rd Dec 202412:15 pmRNSDirector/PDMR Shareholding
20th Dec 202410:47 amRNSPurchase of shares into the EBT
17th Dec 20244:22 pmRNSAnnual Financial Report
12th Dec 20242:59 pmRNSDirector/PDMR Shareholding
6th Dec 20249:51 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.